Clinical Trials Sponsored by Matt Capsey

Total 1369 results

Matt Capsey
County Durham and Darlington NHS Foundation Trust

Completed

Characteristics of Back Pain Attendances at ED

Back Pain
Mattu University

Recruiting

Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients

Depression | Medication Adherence

Ethiopia
MaaT Pharma

Recruiting

Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis (IASO)

Amyotrophic Lateral Sclerosis | ALS

France
MaaT Pharma

Recruiting

Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)

Transplant Complication

Germany, France
MaaT Pharma

Recruiting

MaaT013 as Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients (ARES)

Acute Graft Versus Host Disease in Intestine | Steroid Refractory GVHD

Spain, France, Germany, Austria, Belgium, Italy
Mattu University

Completed

Impact of Medication Therapy Management Intervention on Treatment Outcomes and Medication Adherence Among Adult Patients Comorbid With Diabetes Mellitus and Hypertension at Outpatient Clinics

Hypertension | Diabetes Mellitus

Ethiopia
MaaT Pharma

Completed

Safety and Tolerability Evaluation of MaaT033 (CIMON)

Hematologic Diseases | Chemotherapy Effect

France
MaaT Pharma

Completed

PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (ODYSSEE)

Leukemia, Myeloid, Acute

France
MaaT Pharma

Terminated

Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY (HAPY3)

Intensive Care Units | Fecal Microbiota Transplantation

France
MaaT Pharma

Available

Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease (ATLAS)

Acute Graft Versus Host Disease in Intestine | Steroid Refractory GVHD

France
MaaT Pharma

Completed

Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer (HERACLES)

Fecal Microbiota Transplantation

France, Italy, Poland
MaaT Pharma

Completed

InterventiOnal Study of Bone and Joint Infections Related Gut dysbiosIS (OSIRIS)

Bone and Joint Infection

France
MaaT Pharma

Recruiting

Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013 (ORION)

Steroid Refractory GVHD | Intestinal GVHD

France
Mattu University

Completed

The Effect of Interpersonal Psychotherapy on Quality of Life Among People Living With HIVAIDS

Breif Description: Patients' Quality of Life of

Ethiopia
Matt Smith

Active, not recruiting

Punch vs. Drill Tunnel Use for Anchor Tunnel Creation and Correlation With Post-operative Pain (Punch/Drill)

Rotator Cuff Tears

United States
Mati Therapeutics Inc.

Completed

Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular Pressure

Elevated Intraocular Pressure (IOP)

United States
Mast Therapeutics, Inc.

Completed

Evaluation of Repeat Administration of Purified Poloxamer 188 (EPIC-E)

Sickle Cell Disease

United States
Mati Therapeutics Inc.

Completed

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Glaucoma | Ocular Hypertension (OH)

United States
Mati Therapeutics Inc.

Completed

Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension (CORE)

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.

Completed

Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract

Pain | Inflammation

United States
Mast Therapeutics, Inc.

Completed

Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) (EPIC)

Sickle Cell Disease | Vaso-occlusive Crisis

United States, Belgium, Brazil, Dominican Republic, Jamaica, Jordan, Lebanon, Oman, Panama, Spain, Turkey
Mati Therapeutics Inc.

Completed

A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Glaucoma | Ocular Hypertension (OH)

United States
Mati Therapeutics Inc.

Completed

Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.

Terminated

A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.

Seasonal Allergic Conjunctivitis to Ragweed

Canada
Mati Therapeutics Inc.

Withdrawn

A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Ocular Hypertension | Glaucoma
Mast Therapeutics, Inc.

Completed

Clinical Trial in Patients With Metastatic Colorectal Cancer

Rectal Cancer | Colon Cancer

United Kingdom, Serbia, India, Poland, Romania
GATT Technologies BV

Recruiting

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Liver Diseases | Gallbladder Diseases | Intraoperative Bleeding | Hemorrhage, Surgical

United States
Mati Therapeutics Inc.

Completed

An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake

Dry Eye Syndromes

United States
Heriot-Watt University

Unknown

Injury Epidemiology Within Scottish Professional Football (S-FIS)

Injury;Sports

United Kingdom
Mati Therapeutics Inc.

Completed

A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

Ocular Hypertension | Open-Angle Glaucoma

United States
Mast Therapeutics, Inc.

Completed

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Healthy Volunteers | Renal Impaired | Pharmacokinetics of Vepoloxamer

United States
Mast Therapeutics, Inc.

Terminated

Evaluation of Vepoloxamer in Chronic Heart Failure

Chronic Heart Failure

United States, Australia
Mast Therapeutics, Inc.

Terminated

Evaluation of MST-188 in Acute Lower Limb Ischemia

Acute Limb Ischemia

United States
Mast Therapeutics, Inc.

Completed

ANX-188 Thorough QT/QTc Study in Healthy Volunteers

Healthy

United States
Mati Therapeutics Inc.

Completed

A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Ocular Hypertension | Open Angle Glaucoma

Canada
Mati Therapeutics Inc.

Completed

A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.

Completed

A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Mast Therapeutics, Inc.

Completed

A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer

Advanced Cancer

United States, Argentina, Estonia
Mast Therapeutics, Inc.

Completed

A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.

Healthy Adults

United States
MAST Biosurgery, AG

Completed

Evaluation of Bioresorbable Sheet to Prevent Intra-Abdominal Adhesions in Colorectal Surgeries

Adhesions

Norway
Mast Therapeutics, Inc.

Unknown

5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients

Breast Cancer

Argentina, Mexico, Peru, Russian Federation, Spain
Mast Therapeutics, Inc.

Unknown

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Metastatic Colorectal Cancer | Rectal Cancer | Colon Cancer

United States, Former Serbia and Montenegro
Matti Sällberg

Completed

A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine (OpenCorona1)

COVID-19 Respiratory Infection | COVID-19 Vaccine Adverse Reaction

Sweden
Çanakkale Onsekiz Mart University

Completed

Mindfulness in Childbirth Preparation Education Process

Pregnant Women

Turkey
Çanakkale Onsekiz Mart University

Completed

The Effect of Position on Gastric Residual Volume and Comfort Level in Newborns

Position | Comfort | Newborn, Infant, Disease | Residual

Turkey
Mast Therapeutics, Inc.
CytRx

Completed

Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease

Sickle Cell Anemia
Çanakkale Onsekiz Mart University

Active, not recruiting

The Effect of Respiratory Exercises on Abdominal Distension in Laparoscopic Cholecystectomy Patients

Elective Laparoscopic Cholecystectomy

Turkey
Çanakkale Onsekiz Mart University

Completed

Mindfulness Training in Nurses and Its Effect on Work Stress

Nursing Caries | Consciousness, Level Altered

Turkey
GATT Technologies BV
Avania

Completed

Clinical Safety and Performance of GATT-Patch in Open Liver Surgery

Hemorrhage, Surgical

Netherlands
Çanakkale Onsekiz Mart University

Completed

Periodontal Treatment With Diode Laser in the Patients With Diabetes Melitus

Diabetes Mellitus | Periodontal Disease

Turkey

3

Subscribe